Unraveling the Pathogenesis of Medication-Related Osteonecrosis of the Jaw

Clicks: 3
ID: 338255
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #143 of 143 articles by views in journal of bone and mineral research : the official journal of the american society for bone and mineral research

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 143 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Medication-related osteonecrosis of the jaw (MRONJ) is a serious complication associated with bone-modifying and antiangiogenic therapies. As the use of these agents expands in osteoporosis management and cancer care, the population at risk of MRONJ is increasing. Despite its substantial clinical burden, effective prevention and treatment remain limited by an incomplete understanding of its pathogenesis and of the biological features that may confer susceptibility to the jaws. This review critically synthesizes current evidence across five potentially interacting pathogenic domains: impaired bone remodeling, compromised vascular and lymphatic support, impaired oral soft-tissue healing, microbial dysbiosis and biofilm formation, and immune dysregulation. Systemic comorbidities and concomitant therapies are also considered as potential modifiers of disease susceptibility and clinical course. In addition, we examine jaw-specific susceptibility by integrating evidence from developmental biology, comparative anatomy, cellular pharmacology, and local osteoimmune biology. Together, these observations support a multifactorial model of MRONJ in which drug-specific effects interact with local tissue characteristics and host factors, while the temporal sequence and relative contribution of individual mechanisms remain incompletely defined. A more precise understanding of these interactions may improve risk stratification and inform future preventive and therapeutic strategies.
Reference Key
openalex_W7225125069 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Weidong Liu, Chenghao Jiang, Yili Liu, Fei Jiang, Junjun Jing, Jiahui Du, Xinquan Jiang
Are you one of these authors? Claim your profile
Journal journal of bone and mineral research : the official journal of the american society for bone and mineral research
Year 2026
DOI
10.1093/jbmr/zjag153
URL
https://doi.org/10.1093/jbmr/zjag153
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.